Patents Assigned to Thermo Fisher Scientific Inc.
-
Patent number: 10011836Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. Be selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods compositions, and kits generated through rational design of siRNAs are disclosed, including those directed to the nucleotide sequences for F12.Type: GrantFiled: November 9, 2015Date of Patent: July 3, 2018Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 10006844Abstract: A method of initiating a fluid density measurement includes generating a prime resonance of a test fixture by a startup circuit. The method of initiating a fluid density measurement includes closing a feedback loop in response to generating the prime resonance. The method of initiating a fluid density measurement includes maintaining the prime resonance by closing the feedback loop.Type: GrantFiled: December 3, 2015Date of Patent: June 26, 2018Assignee: Thermo Fisher Scientific Inc.Inventors: Yury A. Bakhirkin, Alexander Joseph Esin, Yanzhong Li
-
Patent number: 9879266Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. Be selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods compositions, and kits generated through rational design of siRNAs are disclosed, including those directed to the nucleotide sequences for HAO1.Type: GrantFiled: November 10, 2015Date of Patent: January 30, 2018Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9839649Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. Be selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods compositions, and kits generated through rational design of siRNAs are disclosed, including those directed to the nucleotide sequences for AAT.Type: GrantFiled: November 9, 2015Date of Patent: December 12, 2017Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9777270Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TTR.Type: GrantFiled: December 10, 2015Date of Patent: October 3, 2017Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9771586Abstract: Efficient sequence specific gene silencing is possible through the use of RNAi technology. By selecting particular RNAi molecules by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of RNAi molecules are disclosed including those directed to nucleotide sequences for ZNF205.Type: GrantFiled: September 1, 2016Date of Patent: September 26, 2017Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9719094Abstract: Efficient sequence specific gene silencing is possible through the use of RNAi technology. By selecting particular RNAi molecules by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of RNAi molecules are disclosed including those directed to nucleotide sequences for SEC61G.Type: GrantFiled: September 2, 2016Date of Patent: August 1, 2017Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9719092Abstract: Efficient sequence specific gene silencing is possible through the use of RNAi technology. By selecting particular RNAi molecules by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of RNAi molecules are disclosed including those directed to nucleotide sequences for CNTD2.Type: GrantFiled: September 2, 2016Date of Patent: August 1, 2017Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9460413Abstract: A storage unit for tracking events associated with an item is disclosed that includes a storage unit, a tracking device, and a processing and/or storage device. The tracking device monitors the presence of an item associated with the storage unit and the temperature of the item at discrete intervals of time. The processing and/or storage device is electrically connected to the tracking device and stores information generated from the tracking device. An automated access system may also be provided that grants access to the storage unit only to authorized users. An external network may also be provided which allows a user to monitor the storage unit including, access to the storage unit, and a temperature of the storage unit.Type: GrantFiled: December 27, 2001Date of Patent: October 4, 2016Assignee: Thermo Fisher Scientific Inc.Inventors: Bryan M. Elwood, Walter Jeff Tipton, Charles G. Butts, Paul M. Steinhoff
-
Patent number: 9360406Abstract: A process and system for self-calibration of a density profiler is disclosed. The process may include measuring a density profile of a fluid in a vessel using a plurality of sensors or a single sensor, and measuring a density profile of the fluid in the vessel using a plurality of sample ports. A density of the fluid proximate a location of at least one of the plurality of sample ports based on the sensor measured density profile may then be interpolated. A density of the fluid proximate a location of at least one of the plurality of sensors based on the sample port measured density profile may also be interpolated. Adjustment of a calibration of at least one of the plurality of sensors may then be made based on both the interpolated sample port density and the interpolated sensor density.Type: GrantFiled: April 17, 2013Date of Patent: June 7, 2016Assignee: Thermo Fisher Scientific Inc.Inventors: Alex Kulik, Michael George Brosseau, Hai Wang
-
Patent number: 9228186Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TTR.Type: GrantFiled: December 5, 2013Date of Patent: January 5, 2016Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 9150862Abstract: Vascular endothelial growth factor A (VEGFA) is a chemical signal produced by cells that stimulates the growth of new blood vessels, and overexpression of VEGFA can lead to undesirable physiological conditions. Through the identification of new siRNA and modifications that improve the silencing ability of these siRNA in vivo, therapeutic compositions and methods have been invented to address the problems associated with this overexpression.Type: GrantFiled: August 27, 2013Date of Patent: October 6, 2015Assignees: Thermo Fisher Scientific Inc., Arrowhead Research CorporationInventors: Anja Smith, Angela Reynolds, Jon E. Chatterton, Xinyu Zhang
-
Patent number: 9091772Abstract: A method, apparatus, and computer program products for controlling gain in a scintillation detector. Calibration count rates, each representing an integral count rate above a different threshold, are obtained from a photomultiplier tube. Photomultiplier tube gain is adjusted if a result from evaluating a relationship of calibration count rates varies from an expected result based on integral count rate versus threshold for a reference peak in the energy spectrum of the radiation source. An additional, different relationship may also be evaluated and an additional gain adjustment performed when a result indicates that the calibration count rates are not from the reference peak. A same radiation source may be used for collecting test counts and calibration counts.Type: GrantFiled: September 14, 2012Date of Patent: July 28, 2015Assignee: Thermo Fisher Scientific Inc.Inventors: Hieu Dinh Vu, Alexander Joseph Esin, Jia Ming Lu
-
Patent number: 8983028Abstract: A method for measuring a density profile of a fluid in a process vessel is disclosed. The method includes emitting gamma rays into the fluid and acquiring a backscattered gamma ray counts distribution using at least one position sensitive gamma ray detector disposed proximate the vessel. The method further includes determining the density profile of the fluid contained in the process vessel based on the backscattered gamma ray counts distribution.Type: GrantFiled: November 16, 2011Date of Patent: March 17, 2015Assignee: Thermo Fisher Scientific Inc.Inventors: Alex Kulik, Alexander Joseph Esin, Nikolay Baturin, Soovo Sen, Michael George Brosseau
-
Patent number: 8937172Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CTNNB1.Type: GrantFiled: February 12, 2013Date of Patent: January 20, 2015Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 8937275Abstract: A method and apparatus in accordance with the present disclosure relate to monitoring gain of a proportional counter. The method includes generating a pulse height spectrum of the proportional counter, defining a first window and a second window within the pulse height spectrum, counting electrical pulses outputted by the proportional counter within the first window of the pulse height spectrum, thereby defining a first window count, counting electrical pulses outputted by the proportional counter within the second window of the pulse height spectrum, thereby defining a second window count, and determining a difference between the first window count and the second window count.Type: GrantFiled: October 12, 2012Date of Patent: January 20, 2015Assignee: Thermo Fisher Scientific Inc.Inventors: Alex Kulik, Alexander Joseph Esin
-
Patent number: 8907077Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.Type: GrantFiled: December 6, 2013Date of Patent: December 9, 2014Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorova, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Patent number: 8883998Abstract: Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.Type: GrantFiled: March 20, 2013Date of Patent: November 11, 2014Assignee: Thermo Fisher Scientific Inc.Inventors: Anastasia Khvorava, Angela Reynolds, Devin Leake, William Marshall, Steven Read, Stephen Scaringe
-
Publication number: 20140316734Abstract: A process and system for self-calibration of a density profiler is disclosed. The process may include measuring a density profile of a fluid in a vessel using a plurality of sensors or a single sensor, and measuring a density profile of the fluid in the vessel using a plurality of sample ports. A density of the fluid proximate a location of at least one of the plurality of sample ports based on the sensor measured density profile may then be interpolated. A density of the fluid proximate a location of at least one of the plurality of sensors based on the sample port measured density profile may also be interpolated. Adjustment of a calibration of at least one of the plurality of sensors may then be made based on both the interpolated sample port density and the interpolated sensor density.Type: ApplicationFiled: April 17, 2013Publication date: October 23, 2014Applicant: THERMO FISHER SCIENTIFIC INC.Inventor: Thermo Fisher Scientific Inc.
-
Patent number: RE45553Abstract: A mass filter apparatus for filtering a beam of ions is described. The apparatus comprises an ion beam source and first and second mass filter stages in series to receive the ion beam. A vacuum system maintains the first and second filter stages at substantially the same operating pressure, below 10?3 torr. The first mass filter stage transmits only ions having a sub-range of mass-to-charge ratios including a selected mass-to-charge ratio. The second filter transmits only ions of the selected mass-to-charge ratio. The second mass filter can achieve high accuracy detection without being subjected to problems such as build-up of material on quadrupole rods, resulting in a distorted electric field close to the rods. The first mass filter acts as a coarse filter, typically transmitting 1% of ions received from the ion source. Thus, the detection accuracy and lifetime of mass spectrometers embodying this invention are greatly improved. A mass filter apparatus for filtering a beam of ions is described.Type: GrantFiled: September 19, 2013Date of Patent: June 9, 2015Assignee: Thermo Fisher Scientific Inc.Inventor: Philip Marriott